// Massimiliano Agostini 1,2 , Margherita Annicchiarico-Petruzzelli 3 , Gerry Melino 1,2 and Alessandro Rufini 4 1 Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK 2 Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy 3 Biochemistry Laboratory IDI-IRCC, Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy 4 Department of Cancer Studies, CRUK Leicester Cancer Centre, University of Leicester, Leicester, UK Correspondence to: Alessandro Rufini, email: // Keywords : p73, p53 family, oxidative stress, metabolism, ROS Received : February 22, 2016 Accepted : April 16, 2016 Published : April 22, 2016 Abstract Reactive oxygen species are involved in both physiological and pathological processes including neurodegeneration and cancer. Therefore, cells have developed scavenging mechanisms to maintain redox homeostasis under control. Tumor suppressor genes play a critical role in the regulation of antioxidant genes. Here, we investigated whether the tumor suppressor gene TAp73 is involved in the regulation of metabolic adaptations triggered in response to oxidative stress. H 2 O 2 treatment resulted in numerous biochemical changes in both control and TAp73 knockout (TAp73-/-) mouse embryonic fibroblasts, however the extent of these changes was more pronounced in TAp73-/- cells when compared to control cells. In particular, loss of TAp73 led to alterations in glucose, nucleotide and amino acid metabolism. In addition, H 2 O 2 treatment resulted in increased pentose phosphate pathway (PPP) activity in null mouse embryonic fibroblasts. Overall, our results suggest that in the absence of TAp73, H 2 O 2 treatment results in an enhanced oxidative environment, and at the same time in an increased pro-anabolic phenotype. In conclusion, the metabolic profile observed reinforces the role of TAp73 as tumor suppressor and indicates that TAp73 exerts this function, at least partially, by regulation of cellular metabolism.
No takes yet. Share an insight, caveat, or question.
Agostini et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: